MétaCan
Menu
Back to cohort
Record W4313590662 · doi:10.1111/pai.13900

Pathogenesis, immunology, and immune‐targeted management of the multisystem inflammatory syndrome in children (MIS‐C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper

2023· article· en· W4313590662 on OpenAlexafffund
Wojciech Feleszko, Magdalena Okarska‐Napierała, Emilie P. Buddingh, Markéta Bloomfield, Anna Šedivá, Carles Bautista-Rodríguez, Helen A. Brough, Philippe Eigenmann, Thomas Eiwegger, Andrzej Eljaszewicz, Stefanie Eyerich, Cristina Gómez‐Casado, Alain Fraisse, J Janda, Rodrigo Jiménez‐Saiz, Tilmann Kallinich, Inge Kortekaas Krohn, Charlotte G. Mørtz, Carmen Riggioni, J. Sastre, Milena Sokołowska, Ziemowit Strzelczyk, Eva Untersmayr, Gerdien A. Tramper‐Stranders

Bibliographic record

VenuePediatric Allergy and Immunology · 2023
Typearticle
Languageen
FieldMedicine
TopicKawasaki Disease and Coronary Complications
Canadian institutionsMcMaster University Medical CentreHospital for Sick ChildrenUniversity of Toronto
FundersInstituto de Salud Carlos IIIHospital for Sick ChildrenAstraZenecaAimmune TherapeuticsEuropean Academy of Allergy and Clinical ImmunologyNational Institutes of HealthSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen ForschungInnovationsfondenNational Science FoundationDanoneCanadian Institutes of Health ResearchRegeneron Pharmaceuticals
KeywordsMedicineMacrophage activation syndromeImmunologyCytokine stormClinical immunologyImmune systemCytokine release syndromeVaccinationSystemic inflammatory response syndromeDiseaseIntensive care medicineSepsisAllergyCoronavirus disease 2019 (COVID-19)ImmunotherapyInfectious disease (medical specialty)ArthritisInternal medicine

Abstract

fetched live from OpenAlex

Multisystem inflammatory syndrome in children (MIS-C) is a rare, but severe complication of coronavirus disease 2019 (COVID-19). It develops approximately 4 weeks after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and involves hyperinflammation with multisystem injury, commonly progressing to shock. The exact pathomechanism of MIS-C is not known, but immunological dysregulation leading to cytokine storm plays a central role. In response to the emergence of MIS-C, the European Academy of Allergy and Clinical Immunology (EAACI) established a task force (TF) within the Immunology Section in May 2021. With the use of an online Delphi process, TF formulated clinical statements regarding immunological background of MIS-C, diagnosis, treatment, follow-up, and the role of COVID-19 vaccinations. MIS-C case definition is broad, and diagnosis is made based on clinical presentation. The immunological mechanism leading to MIS-C is unclear and depends on activating multiple pathways leading to hyperinflammation. Current management of MIS-C relies on supportive care in combination with immunosuppressive and/or immunomodulatory agents. The most frequently used agents are systemic steroids and intravenous immunoglobulin. Despite good overall short-term outcome, MIS-C patients should be followed-up at regular intervals after discharge, focusing on cardiac disease, organ damage, and inflammatory activity. COVID-19 vaccination is a safe and effective measure to prevent MIS-C. In anticipation of further research, we propose a convenient and clinically practical algorithm for managing MIS-C developed by the Immunology Section of the EAACI.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.010
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.211
Teacher spread0.205 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations33
Published2023
Admission routes2
Has abstractyes

Explore more

Same venuePediatric Allergy and ImmunologySame topicKawasaki Disease and Coronary ComplicationsFrench-language works237,207